Clearside Biomedical
CLSD
$1.34
Share price
6.35%
Change (1 day)
31.37%
Change (1 year)
Categories
P/S ratio for Clearside Biomedical (CLSD)
P/S ratio as of April 2024 (TTM): 11.9
According to Clearside Biomedical 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 11.8994. At the end of 2023 the company had a P/S ratio of 8.88.
P/S ratio history for Clearside Biomedical from 2016 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 8.88 | -82.53% |
| 2022 | 50.8 | 815.67% |
| 2021 | 5.55 | -66.94% |
| 2020 | 16.8 | -71.68% |
| 2019 | 59.3 | -94.83% |
| 2018 | > 1000 | 122.79% |
| 2017 | 514 | 45.41% |
| 2016 | 354 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |